Olema Pharmaceuticals, Inc. OLMA Total debt

Total debt at other companies

Eli LillyLLY

$54.91B+37.6%

LON

LeonaBio, Inc.LONA

$691K-38.2%

Oric Pharmaceuticals, Inc.ORIC

$3.3M+2.6%

Opko HealthOPK

$49.94M-7.5%

Stoke Therapeutics, Inc.STOK

$3.42M-42.5%

IDEAYA Biosciences, Inc.IDYA

$28.6M+10.1%

FAQ

What is Olema Pharmaceuticals, Inc.'s total debt?

Olema Pharmaceuticals, Inc. (OLMA) reported total debt of $956K in Q1 2026.

How has Olema Pharmaceuticals, Inc.'s total debt changed year-over-year?

Olema Pharmaceuticals, Inc.'s total debt decreased by 16.7% year-over-year, from $1.15M to $956K.

What is the long-term trend for Olema Pharmaceuticals, Inc.'s total debt?

Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s total debt has grown at a -22.4% compound annual growth rate (CAGR), from $3.29M to $1.19M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.